Shell Asset Management CO Regeneron Pharmaceuticals, Inc. Transaction History
Shell Asset Management CO
- $2.9 Billion
- Q2 2025
A detailed history of Shell Asset Management CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 9,696 shares of REGN stock, worth $6.34 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
9,696
              Previous 9,816
              
        
           1.22%
        
      
          
        Holding current value
$6.34 Million
            Previous $6.23 Million
            
        
           18.25%
        
      
          
        % of portfolio
0.18%
            Previous 0.3%
          
        Shares
	  32 transactions
	
  Others Institutions Holding REGN
# of Institutions
1,437Shares Held
88.9MCall Options Held
1.98MPut Options Held
1.75M- 
    
      Vanguard Group Inc Valley Forge, PA9.42MShares$6.16 Billion0.08% of portfolio
- 
    
      Black Rock Inc. New York, NY8.45MShares$5.52 Billion0.2% of portfolio
- 
    
      Jpmorgan Chase & CO New York, NY5.66MShares$3.7 Billion0.28% of portfolio
- 
    
      State Street Corp Boston, MA4.83MShares$3.16 Billion0.1% of portfolio
- 
    
      Dodge & Cox San Francisco, CA3.83MShares$2.5 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $70.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...